Castle Biosciences (CSTL) EBT Margin Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) EBT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -3,107.00 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 303.00 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -485.00 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 142.00 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 28.00 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 4,440.00 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -201.00 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 2,157.00 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -226.00 |
| 10 | Castle Biosciences | 629.76 Mn | 368.04 Mn | 63.15 Mn | 5,221.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,221.00 |
| Dec 31, 2025 | 5,051.00 |
| Sep 30, 2025 | 5,425.00 |
| Jun 30, 2025 | 1,018.00 |
| Mar 31, 2025 | 6,134.00 |
| Dec 31, 2024 | 6,966.00 |
| Sep 30, 2024 | 5,988.00 |
| Jun 30, 2024 | 4,767.00 |
| Mar 31, 2024 | 1,535.00 |
| Dec 31, 2023 | 2,393.00 |
| Sep 30, 2023 | 1,898.00 |
| Jun 30, 2023 | -2,660.00 |
| Mar 31, 2023 | -7,271.00 |
| Dec 31, 2022 | -6,569.00 |
| Sep 30, 2022 | -9,430.00 |
| Jun 30, 2022 | 147.00 |
| Mar 31, 2022 | -7,562.00 |
| Dec 31, 2021 | -9,443.00 |
| Sep 30, 2021 | 4,271.00 |
| Jun 30, 2021 | 4,068.00 |